The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: Is this a good idea?

American Journal of Cardiology

Volumn 94, Issue 9 SUPPL. 1, 2004, Pages 16-21

  McKenney, James M ^a   Brown, W Virgil ^b   Cohen, Jerome D ^c   Cahill, Edward ^d  

^a National Clinical Research Inc   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d (EC)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; NON PRESCRIPTION DRUG; STATIN;

CONSULTATION; CONSUMER; CONTROLLED STUDY; FOLLOW UP; HEALTH SURVEY; HUMAN; LIPID ANALYSIS; MEDICAL PRACTICE; ONLINE SYSTEM; PATIENT COMPLIANCE; PHARMACIST; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SELF CARE;

EID: 7044239599     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.07.050     Document Type: Article

References (12)

1. US Food and Drug Administration. FDA allows whole oat foods to make health claim on reducing the risk of heart disease. FDA Talk Paper. January 21, 1997
2. US Food and Drug Administration. FDA authorizes new coronary heart disease health claim for plant sterol and plant stanol esters. FDA Talk Paper. September 5, 2000
3. Pasternak RC, McKenney JM, Brown WV, Cahill E, Cohen JD. Understanding physician and consumer attitudes concerning cholesterol management: results from The National Lipid Association surveys. Am J Cardiol 2004;94(suppl):9F-15F
4. National Cholesterol Education Program. Third Report of the NCEP Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III). Washington, DC: National Heart, Lung, and Blood Institute. National Institutes of Health. 2002, NIH publication no. 02-5215
5. Pasternak R.C., Smith S.C., Bairey-Merz C.N., Grundy S.M., Cleeman J.I., Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Stroke. 33:2002;2337-2341
6. National Consumer League. Survey: consumer attitudes toward cholesterol-lowering medications and over-the-counter medication. Available at: http://www.nclnet.org/OTCsurvPR.htm. Accessed May 7, 2004
7. Struble WE, Dooley LY, Van Belle SJ, Larouche SJ. Long-term persistence and compliance with lovastatin 10 mg in a naturalistic nonprescription use study. Paper presented at the 2001 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics; March 8, 2001; Orlando, FL
8. Brass EP. Consumer behavior in the setting of over-the-counter statin availability: lessons from The Consumer Use Study of OTC Mevacor. Am J Cardiol 2004;94(suppl):22F-29F
9. Avorn J., Monette J., Lacour A., Bohn R.L., Monane M., Mogun H., LeLorier J. Persistence of use of lipid-lowering medications a cross-national study. JAMA. 279:1998;1458-1462
10. Schucker B., Wittes J.T., Santanello N.C., et al. Change in cholesterol awareness and action results from national physician and public surveys. Arch Intern Med. 151:1991;666-673
11. Sclar D.A., Robison L.M., Skaer T.L. Pharmacy consultation and over-the-counter medication purchasing outcomes Over-the-Counter Medication Intervention Project Team. J Clin Pharm Ther. 21:1996;177-184
12. LaRosa J.C., He J., Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 282:1999;2340-2346